SEC Form 4 · accession 0001209191-15-045355
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Terrence C Kearney
Director
Period of report
May 19, 2015
Accepted (ET)
May 21, 2015 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 19, 2015 | M | 1,500 | $56.99 | A | 1,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $56.99 | May 19, 2015 | M | 1,500 | D | — | May 16, 2021 | Common Stock | 1,500 | 375 | D |
Explanation of responses
- F1Fully vested.